GFAP and Alzheimer disease: Contrastingly, three separate observational cross-sectional studies totaling over 800 individuals with North American and European backgrounds found no significant difference in diagnostic accuracy of AD between p-tau181 (AUC 0.67–0.87) and GFAP (AUC 0.69–0.86) [164].